Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:38 PM
Ignite Modification Date:
2025-12-24 @ 3:38 PM
NCT ID:
NCT06943092
Eligibility Criteria:
Inclusion Criteria:
* Pregnant women carrying live singleton fetusesat 37-42 weeks' gestational age.
* Consentingparturients who had elective caesarean section, under spinal anaesthesia.
* American Society of Anaesthesiologists (ASA) I-II physical status.
Exclusion criteria
* Caesarean sections under general or epidural anesthesia
* Known allergy to Pentazocine, Diclofenacand or Piroxicam
* Patients with uncontrolled hypertension/ pre-eclampsia or eclampsia
* Multiple gestation
* History of peptic ulcer disease,asthma
* Patients with chronic pain or on long term opioids
* Women with dead fetuses or fetuses with congenital abnormalities
* Patients who are unable to rate the pain due to psychiatric illness or illiteracy.
* Parturients with severe obstetric haemorrhage, and sickle cell haemoglobinopathy
* Those that declined consent to participate in the study despite adequate counselling.
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
15 Years
Maximum Age:
45 Years
Study:
NCT06943092
Study Brief:
Protocol Section:
NCT06943092